Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2018 | An overview of 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias

Arnold Ganser • 4 May 2018
ESH AL 2018
Acute Myeloid Leukemia

Arnold Ganser, MD, from the Hannover Medical School, Hannover, Germany talks about his experience of the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, where he discusses the quality of the presentations being held at the event, the exciting conversations with other experts such as current controversies surrounding acute leukemia research, and the overall atmosphere of the conference.

More from Arnold Ganser

1:41
Finding the right targets for CAR T-cell therapy in AML
Arnold Ganser • 4 May 2018
2:28
Midostaurin: the first drug to receive approval for AML since 2000
Arnold Ganser • 4 May 2018
1:37
Overcoming the issues with clinical trial recruitment
Arnold Ganser • 4 May 2018
3:00
The devastating effects of relapsed or refractory AML
Arnold Ganser • 4 May 2018

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals